CNS Delivery Frontiers, Enabling Oligonucleotide Therapeutics for Neurological Disorders

Time: 12:30 pm
day: Conference Day One

Details:

• Latest innovations in crossing the blood–brain barrier with oligonucleotide drugs
• Design considerations for enabling safe and effective CNS delivery

Speakers:

Cody Desjardins Cody Desjardins, Ph.D., is Senior Director at Dyne Therapeutics, where he has helped pioneer targeted delivery approaches for neuromuscular diseases. With prior experience at Sarepta Read more